Noticias del Martes 10 de Enero de 2017

 

Contribución del microbioma uterino en el desarrollo del cáncer de endometrio.

Investigación original: Walther-António MR, et al. Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med. 2016 Nov 25;8(1):122. Doi: http://dx.doi.org/10.1186/s13073-016-0368-y

Fuente: Mayo Clinic researchers: Vaginal microbes point toward early detection and screening for endometrial cancer. http://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-vaginal-microbes-point-toward-early-detection-and-screening-for-endometrial-cancer/

 

 

Diseño de estrategias para implantar la farmacogenómica en Europa.

Investigación original: van der Wouden CH, et al. Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium. Clin Pharmacol Ther. 2016 Dec 27. doi: http://dx.doi.org/10.1002/cpt.602

 

 

Diagnóstico de los síndromes de deficiencia de la creatinina.

Investigación original:  Sharer JD, et al. Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics. Genet Med. 2017 Jan 5. doi: http://dx.doi.org/10.1038/gim.2016.203

 

 

Caracterización genómica del carcinoma esofágico.

Investigación original: Cancer Genome Atlas Research Network et al. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017 Jan 4. doi: http://dx.doi.org/10.1038/nature20805

 

 

La inhibición de  la proteína NOS2 previene y revierte el síndrome de Marfan.

Investigación original: Oller J, et al. Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome. Nat Med. 2017 Jan 9. doi: http://dx.doi.org/10.1038/nm.4266

Fuente: http://www.nature.com/nm/journal/vaop/ncurrent/full/nm.4266.html

 

 

Variantes genéticas que contribuyen a la susceptibilidad a la enfermedad de Crohn.

Investigación original: Lee JC, et al. Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn’s disease. Nat Genet. 2017 Jan 9. doi: http://dx.doi.org/10.1038/ng.3755

Fuente: Crohn’s disease risk and prognosis determined by different genes, study finds. http://www.cam.ac.uk/research/news/crohns-disease-risk-and-prognosis-determined-by-different-genes-study-finds

 

 

Características genómicas del cáncer de próstata localizado.

Investigación original: Fraser M, et al. Genomic hallmarks of localized, non-indolent prostate cancer. Nature. 2017 Jan 9. doi: http://dx.doi.org/10.1038/nature20788

Fuente: Prostate cancer researchers find genetic fingerprint identifying how, when disease spreads. http://www.uhn.ca/corporate/News/PressReleases/Pages/prostate_cancer_researchers_discover_genetic_fingerprint_to_identify_how_and_when_disease_initially_spreads.aspx

 

 

Si te ha gustado el artículo, suscríbete ahora de forma gratuita a la Revista Genética Médica y recíbela cada 2 semanas.


Acepto el Aviso Legal

Deja un comentario